Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Healios Debt to Equity Ratio: 1.143 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.143 |
| September 30, 2023 | 1.240 |
| June 30, 2023 | 2.134 |
| March 31, 2023 | 1.792 |
| December 31, 2022 | 1.572 |
| September 30, 2022 | 1.497 |
| June 30, 2022 | 2.649 |
| March 31, 2022 | 1.722 |
| December 31, 2021 | 1.337 |
| September 30, 2021 | 1.083 |
| June 30, 2021 | 1.983 |
| March 31, 2021 | 1.570 |
| December 31, 2020 | 1.409 |
| September 30, 2020 | 1.099 |
| June 30, 2020 | 0.8794 |
| March 31, 2020 | 0.7638 |
| December 31, 2019 | 0.8178 |
| September 30, 2019 | 1.121 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.2851 |
| March 31, 2019 | 0.2661 |
| December 31, 2018 | 0.1878 |
| September 30, 2018 | 0.2179 |
| June 30, 2018 | 0.2119 |
| March 31, 2018 | 0.1486 |
| December 31, 2017 | 0.1467 |
| September 30, 2017 | 0.1819 |
| June 30, 2017 | 0.1864 |
| March 31, 2017 | 0.3324 |
| December 31, 2016 | 0.4171 |
| September 30, 2016 | 0.3969 |
| June 30, 2016 | 0.3714 |
| March 31, 2016 | 0.345 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2851
Minimum
Jun 2019
2.649
Maximum
Jun 2022
1.374
Average
1.337
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.6918 |
| Nxera Pharma Co Ltd | 1.035 |
| PeptiDream Inc | 0.5507 |
| Stemcell Holdings Inc | -- |
| AnGes Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 107.46M |
| Total Liabilities (Quarterly) | 80.04M |
| Shareholders Equity (Quarterly) | 27.34M |
| Current Ratio | 1.486 |
| Net Debt Paydown Yield | 0.30% |